You are here:

Price to sales update

Created:
21 April 2008
Written by:
David Stevenson

Overall, this portfolio has cut its total losses by more than 3 per cent in the last month, moving from a total loss of over 17 per cent to 14 per cent. Excluding the shares sold off in in February (William Hill, Morgan Sindall, Kier and Galliford Try), the current portfolio is up more than 5 per cent.

Advertising

Of the recently recommended shares, Dimension is up 4 per cent with United Drug up marginally at 0.3 per cent.

There are no new additions or deletions from the portfolio this month.

TRACKING STOCK SCREEN PORTFOLIOS:

You can now track the performance of the New Price to Sales Ratio portfolio online; the link appears below.

We assume an initial investment of £1,000 in each stock, so the number of shares is based on this.

If a holding appears as zero, it is a former holding that has been sold; click on the 'history' link for details of the prices at which it was traded.

The 'Totals' line represents the value of current open positions and the profit/loss on those positions.

The 'Cash balance' line represents the total funds committed to the portfolio since its inception, net of any receipts from the sale of shares.

Click here to access the new price/sales ratio portfolio.

  • Back to top

Products and Services from Barclays Stockbrokers.

The UK’s No.1 Stockbroker

Stocks and Shares

Contracts for Difference

Financial Spread Trading

Gilts and Bonds

Funds Market

FX

Education Centre

Trading Simulator

Advertorial Feature

Spread your risks with spread trading

With so many big moves in the world's financial markets, there have seldom been more opportunities around for spread traders. Isn't it time you joined them?

by Dominic Piccarda